Who are the true warriors of the earth?
Those with Lp(a)?
--Postmeno women (reduced estrogen)
--African Americans and Africans (natives, fishing tribes along the Nile, and Saharan residents including Cleopatra's descendants)
Are the Lp(a) carriers superior with their resistance against scurvy, vitamin C deficiency, superiority against cancers/infections? Are these the mythical warrior race? The Amazonians?
Do they survive short-term life-sentences with no consequences...as long as they follow a 'warrior lifestyle'?
--meat, milk, blood, organ meats, fish, seafood?
--no grains? no refined carbs... ?
--frequent high intensity battle, training?
--frequent intermittent fasting?
--stress control -- control of Type A and Type D tendencies?
It would appear so to me...
WCCA guy brings up Rath's theory on the TYP forum regarding multiple DNA breaks with scurvy and any other nutritional deficiencies to increase the DNA variations that would bring about EVOLUTION.
Why Cholesterol is Not the Cause of Heart Disease
Tx for Lp(a) per Rath:
--high dose vit C (ascorbic acid)
Where are the food sources rich in Lysine?
--abalone, fish, caviar, mollusks, meat, eggs, pork, poultry, soy (tofu, defatted soy flour, isolated soy protein), eggs, fermented dairy (particularly parmesan), nuts, spirulina, fenugreek seed, soaked legumes, cheese (blue, camembert, gruyere -- yea stinkier the better)
Unfortunately when Lp(a) is uncontrolled, dysregulation of vascular beds occurs, ie ED, retinopathy, neuropathy, retinopathy, retinal strokes, carotid disease, coronary disease, peripheral vascular disease and erectile dysfunction. Lp(a) may be uncontrolled with non-adherence with a warrior-race lifestyle ala '300' movie about love & war -- where less than 10% BF-RIPPED-low Lp(a)-abs 'n pecs dominate -- enjoy Lena Headey uncensored... or Breaking Benjamin's BLOW ME AWAY)
- Egyptian researchers: El-Latif MA, Makhlouf AA, Moustafa YM, Gouda TE, Niederberger CS, Elhanbly SM.
Diagnostic value of nitric oxide, lipoprotein(a), and malondialdehyde levels in the peripheral venous and cavernous blood of diabetics with erectile dysfunction.
Int J Impot Res. 2006 Nov-Dec;18(6):544-9. Epub 2006 Apr 20.
- More insights from researchers on Egyptian populations demonstrating a difference in male v. female babies: AbouGhalia AH, Khater LM, Abd El-Wahed MA, El-Badrawy MF.
Lipoprotein (a) and lipid profile in neonates from mothers with three different types of diabetes mellitus.
Clin Biochem. 2003 Oct;36(7):563-9.
- MetSyn also shown to be dangerous combination with Lp(a) as recognized by this researcher from Cairo, Egypt: Wassef GN.
Lipoprotein (a) in android obesity and NIDDM: a new member in 'the metabolic syndrome'.
Biomed Pharmacother. 1999 Dec;53(10):462-5. Review.
- Ancient wheat afflicted ancient Egyptians as it afflicts us now: Nerlich AG, Rohrbach H, Zink A.
[Paleopathology of ancient Egyptian mummies and skeletons. Investigations on the occurrence and frequency of specific diseases during various time periods in the necropolis of Thebes-West]
Pathologe. 2002 Sep;23(5):379-85. Epub 2002 Aug 21. German.
- Valentine RJ, Grayburn PA, Vega GL, Grundy SM.
Lp(a) lipoprotein is an independent, discriminating risk factor for premature peripheral atherosclerosis among white men.
Arch Intern Med. 1994 Apr 11;154(7):801-6.
- Valentine RJ, Kaplan HS, Green R, Jacobsen DW, Myers SI, Clagett GP.
Lipoprotein (a), homocysteine, and hypercoagulable states in young men with premature peripheral atherosclerosis: a prospective, controlled analysis.
J Vasc Surg. 1996 Jan;23(1):53-61, discussion 61-3.
- Tesch GH. (Australian kidney dept -- excellent -- oxLDL and Lp(a)-- immune system brilliance)
Role of macrophages in complications of type 2 diabetes.
Clin Exp Pharmacol Physiol. 2007 Oct;34(10):1016-9. Review.
- Cheng SW, Ting AC, Wong J.
Lipoprotein (a) and its relationship to risk factors and severity of atherosclerotic peripheral vascular disease.
Eur J Vasc Endovasc Surg. 1997 Jul;14(1):17-23.
- Dahlén GH, Srinivasan SR, Stenlund H, Wattigney WA, Wall S, Berenson GS.
The importance of serum lipoprotein (a) as an independent risk factor for premature coronary artery disease in middle-aged black and white women from the United States.
J Intern Med. 1998 Nov;244(5):417-24.
- Deepa R, Mohan A, Rema M, Haranath SP, Saravanan G, Mohan V.
Lipoprotein(a) in South Indian type 2 diabetic subjects in relation to diabetic vascular complications.
J Assoc Physicians India. 2002 May;50(5):657-61.
- Paultre F, Pearson TA, Weil HF, Tuck CH, Myerson M, Rubin J, Francis CK, Marx HF, Philbin EF, Reed RG, Berglund L.
High levels of Lp(a) with a small apo(a) isoform are associated with coronary artery disease in African American and white men.
Arterioscler Thromb Vasc Biol. 2000 Dec;20(12):2619-24.
- Parlavecchia M, Pancaldi A, Taramelli R, Valsania P, Galli L, Pozza G, Chierchia S, Ruotolo G.
Evidence that apolipoprotein(a) phenotype is a risk factor for coronary artery disease in men les than 55 years of age. Am J Cardiol. 1994 Aug 15;74(4):346-51. PMID: 8059696
- Bostom AG, Cupples LA, Jenner JL, Ordovas JM, Seman LJ, Wilson PW, Schaefer EJ, Castelli WP.
Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study.
JAMA. 1996 Aug 21;276(7):544-8.
- Jenkins AJ, Rowley KG, Lyons TJ, Best JD, Hill MA, Klein RL.
Lipoproteins and diabetic microvascular complications.
Curr Pharm Des. 2004;10(27):3395-418. Review.
- Asakawa H, Tokunaga K, Kawakami F.
Comparison of risk factors of macrovascular complications. Peripheral vascular disease, cerebral vascular disease, and coronary heart disease in Japanese type 2 diabetes mellitus patients.
J Diabetes Complications. 2000 Nov-Dec;14(6):307-13.
- Ghorbanihaghjo A, Javadzadeh A, Argani H, Nezami N, Rashtchizadeh N, Rafeey M, Rohbaninoubar M, Rahimi-Ardabili B.
Lipoprotein(a), homocysteine, and retinal arteriosclerosis.
Mol Vis. 2008 Sep 15;14:1692-7.
- Funatsu H, Shimizu E, Noma H, Mimura T, Hori S.
Association between serum lipoprotein (a) level and progression of non-proliferative diabetic retinopathy in Type 2 diabetes.
Acta Ophthalmol. 2008 Aug 11. [Epub ahead of print]